Inflammatory bowel disease, such as ulcerative colitis or Crohns disease
Several additional limitations should be considered when interpreting the present findings
Other serious side effects may include pancreatitis, changes in vision, low blood sugar when combined with insulin or sulfonylureas, dehydration leading to kidney problems, severe gastrointestinal symptoms, gallbladder issues, and serious allergic reactions
In this study, GLP-1 receptor agonist therapy correlated with a lower incidence of severe liver events compared with dipeptidyl peptidase-4 (DPP-4) inhibitors (16.9 vs
Losing fat means also losing the fat-soluble toxins that have accumulated over the years
GLP-1 drugs like semaglutide and tirzepatide slow gastric emptying, increase satiety signaling, and improve glucose homeostasis